Skip to content

Clinical trials

Recruiting Anemia, Refractory, with Excess of Blasts trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Status: Recruiting Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20131
20141
20161
20171
20182
20191
20203
20213
20232
20242
202511
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Fred Hutchinson Cancer Center2
Masonic Cancer Center, University of Minnesota2
National Cancer Institute (NCI)2
The First Affiliated Hospital of Soochow University2
ARCE Therapeutics, Inc.1
Apollo Therapeutics Ltd1
Center for International Blood and Marrow Transplant Research1
Chaser Therapeutics, Inc.1
Children's Hospital Medical Center, Cincinnati1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts37
Leukemia, Myeloid, Acute26
Leukemia, Myelomonocytic, Chronic9
Myelodysplastic Syndromes7
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Leukemia5
Myeloproliferative Disorders5
Leukemia, Biphenotypic, Acute4
Anemia, Aplastic3
Lymphoma, Non-Hodgkin3

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.